Literature DB >> 24523384

ANG-(3-4) inhibits renal Na+-ATPase in hypertensive rats through a mechanism that involves dissociation of ANG II receptors, heterodimers, and PKA.

Juliana Dias1, Fernanda M Ferrão, Flavia Axelband, Adriana K Carmona, Lucienne S Lara, Adalberto Vieyra.   

Abstract

The physiological roles of ANG-(3-4) (Val-Tyr), a potent ANG II-derived peptide, remain largely unknown. The present study 1)investigates whether ANG-(3-4) modulates ouabain-resistant Na(+)-ATPase resident in proximal tubule cells and 2) verifies whether its possible action on pumping activity, considered the fine tuner of Na(+) reabsorption in this nephron segment, depends on blood pressure. ANG-(3-4) inhibited Na(+)-ATPase activity in membranes of spontaneously hypertensive rats (SHR) at nanomolar concentrations, with no effect in Wistar-Kyoto (WKY) rats or on Na(+)-K(+)-ATPase. PD123319 (10(-7) M) and PKA(5-24) (10(-6) M), an AT2 receptor (AT2R) antagonist and a specific PKA inhibitor, respectively, abrogated this inhibition, indicating that AT2R and PKA are central in this pathway. Despite the lack of effect of ANG-(3-4) when assayed alone in WKY rats, the peptide (10(-8) M) completely blocked stimulation of Na(+)-ATPase induced by 10(-10) M ANG II in normotensive rats through a mechanism that also involves AT2R and PKA. Tubular membranes from WKY rats had higher levels of AT2R/AT1R heterodimers, which remain associated in 10(-10) M ANG II and dissociate to a very low dimerization state upon addition of 10(-8) M ANG-(3-4). This lower level of heterodimers was that found in SHR, and heterodimers did not dissociate when the same concentration of ANG-(3-4) was present. Oral administration of ANG-(3-4) (50 mg/kg body mass) increased urinary Na(+) concentration and urinary Na(+) excretion with a simultaneous decrease in systolic arterial pressure in SHR, but not in WKY rats. Thus the influence of ANG-(3-4) on Na(+) transport and its hypotensive action depend on receptor association and on blood pressure.

Entities:  

Keywords:  ANG II receptors; ANG-(3–4); heterodimerization; kidney proximal tubules; ouabain-resistant Na+-ATPase; spontaneously hypertensive rats

Mesh:

Substances:

Year:  2014        PMID: 24523384     DOI: 10.1152/ajprenal.00488.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

1.  Luminal ANG II is internalized as a complex with AT1R/AT2R heterodimers to target endoplasmic reticulum in LLC-PK1 cells.

Authors:  Fernanda M Ferrão; Luiza H D Cardoso; Heather A Drummond; Xiao C Li; Jia L Zhuo; Dayene S Gomes; Lucienne S Lara; Adalberto Vieyra; Jennifer Lowe
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-03

Review 2.  Renin-angiotensin system in the kidney: What is new?

Authors:  Fernanda M Ferrão; Lucienne S Lara; Jennifer Lowe
Journal:  World J Nephrol       Date:  2014-08-06

Review 3.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

4.  Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.

Authors:  Christopher J Coke; Kisha A Scarlett; Mahandranauth A Chetram; Kia J Jones; Brittney J Sandifer; Ahriea S Davis; Adam I Marcus; Cimona V Hinton
Journal:  J Biol Chem       Date:  2016-02-03       Impact factor: 5.157

Review 5.  Is angiotensin-(3-4) (Val-Tyr), the shortest angiotensin II-derived peptide, opening new vistas on the renin-angiotensin system?

Authors:  Juliana Dias; Flavia Axelband; Lucienne S Lara; Humberto Muzi-Filho; Adalberto Vieyra
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017-01       Impact factor: 1.636

6.  Aldosterone nongenomically induces angiotensin II receptor dimerization in rat kidney: role of mineralocorticoid receptor and NADPH oxidase.

Authors:  Kittisak Sinphitukkul; Krissanapong Manotham; Somchai Eiam-Ong; Somchit Eiam-Ong
Journal:  Arch Med Sci       Date:  2019-08-22       Impact factor: 3.318

7.  Investigation of Receptor Heteromers Using NanoBRET Ligand Binding.

Authors:  Elizabeth K M Johnstone; Heng B See; Rekhati S Abhayawardana; Angela Song; K Johan Rosengren; Stephen J Hill; Kevin D G Pfleger
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

8.  Angiotensin-(3-4) normalizes the elevated arterial blood pressure and abnormal Na+/energy handling associated with chronic undernutrition by counteracting the effects mediated by type 1 angiotensin II receptors.

Authors:  Amaury Pereira-Acácio; João P M Veloso-Santos; Luiz F Nossar; Gloria Costa-Sarmento; Humberto Muzi-Filho; Adalberto Vieyra
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.